Differential expression of RNASE4 in cancer of the vulva.

In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of ribonuclease A family member 4, encoded by RNASE4, in cancer of the vulva. RNASE4 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).

Differential expression of LTBP4 in cancer of the vulva.

In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of latent transforming growth factor beta binding protein 4, encoded by LTBP4, in cancer of the vulva. LTBP4 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).

Differential expression of ACACB in cancer of the vulva.

In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of acetyl-CoA carboxylase beta, encoded by ACACB, in cancer of the vulva. ACACB may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).

Differential expression of KLHL3 in cancer of the vulva.

In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of kelch-like family member 3, encoded by KLHL3, in cancer of the vulva. KLHL3 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).

Differential expression of CHPT1 in cancer of the vulva.

In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of choline phosphotransferase 1, encoded by CHPT1, in cancer of the vulva. CHPT1 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).

Differential expression of ZNF629 in cancer of the vulva.

In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of zinc finger protein 629, encoded by ZNF629, in cancer of the vulva. ZNF629 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).

Differential expression of MSANTD2 in cancer of the vulva.

In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of Myb/SANT DNA binding domain-containing 2, encoded by MSANTD2, in cancer of the vulva. MSANTD2 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).

Differential expression of LHX6 in cancer of the vulva.

In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of LIM homeobox 6, encoded by LHX6, in cancer of the vulva. LHX6 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).